Innate Pharma Stock (NASDAQ: IPHA) stock price, news, charts, stock research, profile.
Open | $2.17 |
Close | - |
Volume / Avg. | 3.57K / 6.54K |
Day Range | $2.17 - $2.24 |
52 Wk Range | 1.81 - 3.15 |
Market Cap | $182.95M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 0.14% |
Days to Cover | 9.73 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Innate Pharma (NASDAQ:IPHA) through any online brokerage.
Other companies in Innate Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Atossa Therapeutics (NASDAQ:ATOS).
Innate Pharma has a consensus price target of $10.83.
The stock price for Innate Pharma (NASDAQ: IPHA) is $2.26 last updated September 23, 2024 at 7:28 AM EDT.
There are no upcoming dividends for Innate Pharma.
Innate Pharma’s H1 earnings are confirmed for Thursday, September 12, 2024.
There is no upcoming split for Innate Pharma.
Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.